Zymeworks (ZYME) FCF Margin (2021 - 2026)

Zymeworks (ZYME) reported FCF Margin of 1902.74% for Q1 2026, down 189011.0% on a YoY basis from N/an in Q1 2025, and down 341.46% sequentially from 431.01% in Q4 2025.

Zymeworks (ZYME) FCF Margin (2021 - 2026) Analysis & Trends

Zymeworks (ZYME) has 6 years of FCF Margin data on file, last reported at 1902.74% in Q1 2026.

  • For the quarter ending Q1 2026, FCF Margin fell 189011.0% year-over-year to 1902.74%; the trailing twelve-month figure through Mar 2026 stood at 94.66% (down 1135.0% YoY), and the FY2025 full-year result was 32.58%, up 11426.0% from the prior year.
  • FCF Margin retreated to 1902.74% in Q1 2026, from 431.01% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 100.87% in Q4 2022 to a low of 3109.08% in Q1 2022.
  • A 5-year average of 603.96% and a median of 134.78% in 2024 frame the typical range for FCF Margin.
  • Across the five-year window, FCF Margin jumped 287417 bps in 2023 and tumbled 189011 bps in 2026, its largest moves.
  • Tracing ZYME's FCF Margin over 5 years: stood at 100.87% in 2022, then fell by 7 bps to 94.11% in 2023, then sank by 243 bps to 134.78% in 2024, then slumped by 220 bps to 431.01% in 2025, then tumbled by 341 bps to 1902.74% in 2026.
  • Business Quant data shows ZYME's FCF Margin at 1902.74% in Q1 2026, 431.01% in Q4 2025, and 115.24% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) FCF Margin (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 10.45%
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 43.35%
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn 23.53%
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Zymeworks 1.73 Bn 1.36 Bn - -1,902.74%

Historic Data

Download Data
DateValue
Mar 31, 2026 -1,902.74%
Dec 31, 2025 -431.01%
Sep 30, 2025 -115.24%
Jun 30, 2025 23.72%
Mar 31, 2025 -12.63%
Dec 31, 2024 -134.78%
Sep 30, 2024 -42.37%
Jun 30, 2024 -133.92%
Mar 31, 2024 -375.62%
Dec 31, 2023 94.11%
Sep 30, 2023 -264.13%
Jun 30, 2023 -102.84%
Mar 31, 2023 -234.91%
Dec 31, 2022 100.87%
Sep 30, 2022 -2,570.32%
Jun 30, 2022 -1,056.36%
Mar 31, 2022 -3,109.08%
Dec 31, 2021 -634.91%